Dr Caitriona Creely, NCP and ND for Health, HRB DOCTORID conference, Carton House July 25th 2012

1. EU health research
funding opportunities
Dr Caitriona Creely, NCP and ND for Health, HRB
DOCTORID conference, Carton House
July 25th 2012
1

2. Key messages
• Final call in FP7 Health has launched
• No more calls until 2014
• Overview of collaborative research
opportunities of potential interest to
DOCTORID
• Looking to the next EU research programme:
HORIZON2020
2

3. Final call in FP7 Health
• FP7 Health: annual Call for proposals just
published
• Two stage system
• Stage 1 applications:10 pages in length
• Deadlines for stage 1 submission
INNOVATION-1 (indicative deadline 2 October
2012)
INNOVATION-2 (indicative deadline 25 September
2012)
3

4. Minimum requirements
Proposals must
• Be within scope of topic in published work
programme
• Have minimum number of eligible,
independent participants/ countries from
EU Member States MS/AC or as set out in
the Work Programme *
• Observe maximum budget for the topic you
are applying for (including any specific
budget for SMEs)
* US partners can apply to FP7 Health and be funded, but they
4
will not count towards the minimum 3 MS/AC required

5. Topics of potential
interest to DOCTORID
1. CER in health systems and HSR
2. Preparing the future for health research and
innovation
5

6. 6

7. 500,000 available per project
7

8. Other Opportunities in Health
Download the research topics for the
Health theme on
http://ec.europa.eu/research/participants/portalplus/static/docs/calls/fp7/com
mon/32745-annex_4_to_the_decision_health_wp2013-
18_june_for_egreffe_en.pdf
8

9. Support for Irish applicants
• National Contact Points
• Academic Coordinator Support
• Travel Support
9

10. Horizon2020 (2014-2020)
• Next multi-annual EU funding programme
• Three pillars:
 Excellent science
 Industrial Leadership
 Societal Challenges
• Three documents to be negotiated
o Regulation (agreed by Council May 2012)
o Rules for Participation (under neg.)
o Specific Programme (content, under neg.)
10

11. FP7 Cooperation themes →
HORIZON2020 challenges
1. Health (€6.1b) • Health, Demographic
Change and Well-being
2. Food, agriculture, fisheries and
biotechnology • Food Security, Sustainable
3. Information and communication
Agriculture and Forestry,
technologies
Marine, Maritime and
inland water
4. Nanosciences, nanotechnologies,
materials
• Secure, Clean and Efficient
and new production
Energy
technologies • Smart, Green and
5. Energy Integrated Transport
6. Environment (including climate • Climate Action, Resource
change) Efficiency and Raw
Materials
7. Transport (including
aeronautics) • Inclusive, Innovative and
8. Socio-economic sciences and the
Reflective Societies
humanities • Secure Societies
9. Security
10. Space

12. Health, Demographic Change
and Well-being
1.8. Treating disease
There is a need to support the improvement of cross-cutting support
technologies for…. to develop improved medical and assistive devices and
systems;……These improvements will facilitate the development of new,
more efficient, effective and sustainable treatments for disease and for the
management of disability.
1.9. Transferring knowledge to clinical practice and scalable
innovation actions
…….Similarly, support for the transfer of other types of interventions such as
those related to independent living into real world environments will be
provided.
1.12. Active ageing, independent and assisted living
Multidisciplinary advanced and applied research and innovation with
behavioural, gerontological, digital and other sciences is needed for cost
effective user-friendly solutions for active, independent and assisted daily
living (in the home, the workplace, etc.) for the ageing population and
people with disabilities.
12
Excerpts from Specific Programme, version 9 July, DS 1505/12

13. Inclusive, Innovative and
Reflective Societies
….. understand, analyse and develop social, economic and political
inclusion, combat poverty, enhance human rights, digital inclusiveness,
equality, solidarity and inter-cultural dynamics by supporting interdisciplinary
research, indicators, technological advances, organisational solutions and
new forms of collaboration and co-creation.
6.1.2 Trusted organisations, practices, services and policies that are
necessary to build resilient, inclusive, participatory, open and creative
societies in Europe, in particular taking into account migration, integration
and demographic change
Given the increasing socio-economic importance of digital inclusion, research and
large-scale innovation actions will promote inclusive ICT solutions and the effective
acquisition of digital skills leading to the empowerment of citizens and a competitive
workforce. Emphasis will be given to new technological advances that will enable a
radical improvement in personalisation, user-friendliness and accessibility through a
better understanding of citizen, consumer and user behaviours and values, including
persons with disabilities. This will require an "inclusion by design" research and
innovation approach.
13
Excerpts from Specific Programme, version 9 July, DS 1505/12

14. H2020 negotiations
• Negotiation began January 2012 through
Research Working Group: member states will
have opportunity to go through proposal line by
line
• Brussels research attaché (DJEI/DFA) will
represent Ireland in negotiations on H20
• Ireland’s agencies and govt. Departments
asked to provide input during negotiations
• Content finalised by end 2013
• HORIZON2020 will launch on 1 Jan 2014

15. Thank You
ccreely@hrb.ie
15

16. Health NCP contact details
Dr Caitriona Creely (Also Delegate for Health)
Ccreely@hrb.ie
Kay Duggan-Walls (academics/clinicians)
kdugganwalls@hrb.ie
Dr Ciarán Duffy (IMI, industry partners)
Ciaran.duffy@enterprise-ireland.com

17. CER definition, (US) Federal
Coordinating Council for CER
• Comparative effectiveness research is the conduct and synthesis of research comparing
the benefits and harms of different interventions and strategies to prevent, diagnose, treat
and monitor health conditions in “real world” settings. The purpose of this research is to
improve health outcomes by developing and disseminating evidence-based information to
patients, clinicians, and other decision-makers, responding to their expressed needs,
about which interventions are most effective for which patients under specific
circumstances.
• To provide this information, comparative effectiveness research must assess a
comprehensive array of health-related outcomes for diverse patient populations and
subgroups.
• Defined interventions compared may include medications, procedures, medical and
assistive devices and technologies, diagnostic testing, behavioural change, and delivery
system strategies.
• This research necessitates the development, expansion, and use of a variety of data
sources and methods to assess comparative effectiveness and actively disseminate the
results.
• The definition above is not meant to exclude randomized trials; however, these trials
would need comparator arms other than placebo and be representative of populations
seen in “real world” practice.
For more information: 17
CCreely@hrb.ie

18. EU REGULATION (2014-2020) Proposed budget
I Excellent science, of which: 24598
1. The European Research Council 13268
2. Future and Emerging Technologies 3100
3. Marie Curie actions on skills, training and career development 5752
4. European research infrastructures (including eInfrastructures) 2478
II Industrial leadership, of which: 17938
1. Leadership in enabling and industrial technologies* 13781 of which 436 for EIT
2. Access to risk finance** 3538
3. Innovation in SMEs 619
III Societal challenges, of which 31748
1. Health, demographic change and wellbeing; 8033 of which 254 for EIT
2. Food security, sustainable agriculture, marine and maritime research 4152 of which 131 for EIT
and the bio- economy;
3. Secure, clean and efficient energy 5782 of which 183 for EIT
4. Smart, green and integrated transport 6802 of which 215 for EIT
5. Climate action, resource efficiency and raw materials 3160 of which 100 for EIT
6. Inclusive, innovative and secure societies 3819 of which 121 for EIT
European Institute of Innovation and Technology (EIT) 1360 + 1440***
Non-nuclear direct actions of the Joint Research Centre 1962
TOTAL EU REGULATION 77606
EURATOM REGULATION (2014-2018)
I. Indirect actions 1009
II. Direct actions of the Joint Research Centre 656
TOTAL EURATOM REGULATION 1665 13b p.a.